173 related articles for article (PubMed ID: 28342102)
1. The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
Choi SY; Kim YK; Min JH; Cha DI; Jeong WK; Lee WJ
Eur Radiol; 2017 Oct; 27(10):4383-4393. PubMed ID: 28342102
[TBL] [Abstract][Full Text] [Related]
2. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
Kim YK; Lee YH; Kim CS; Lee MW
Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of hepatic abscess from metastasis on contrast-enhanced dynamic computed tomography in patients with a history of extrahepatic malignancy: emphasis on dynamic change of arterial rim enhancement.
Oh JG; Choi SY; Lee MH; Lee JE; Yi BH; Kim SS; Min JH; Lee B
Abdom Radiol (NY); 2019 Feb; 44(2):529-538. PubMed ID: 30196363
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.
Chang AI; Kim YK; Min JH; Lee J; Kim H; Lee SJ
Abdom Radiol (NY); 2019 Apr; 44(4):1395-1406. PubMed ID: 30515535
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
6. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
[TBL] [Abstract][Full Text] [Related]
7. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
Choi SH; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
J Comput Assist Tomogr; 2013; 37(6):849-55. PubMed ID: 24270105
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.
Kim YK; Park G; Kim CS; Yu HC; Han YM
Br J Radiol; 2012 May; 85(1013):539-47. PubMed ID: 22556405
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging.
Park HJ; Kim YK; Min JH; Lee J; Lee SJ; Lee ES; Ahn S
Abdom Radiol (NY); 2019 Sep; 44(9):3115-3126. PubMed ID: 31134313
[TBL] [Abstract][Full Text] [Related]
10. Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer.
Sun HY; Lee JM; Park HS; Yoon JH; Baek JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Jul; 38(1):138-47. PubMed ID: 23281093
[TBL] [Abstract][Full Text] [Related]
11. Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging.
Moon JY; Kim SH; Choi SY; Hwang JA; Lee JE; Lee J
Jpn J Radiol; 2018 Aug; 36(8):489-499. PubMed ID: 29876721
[TBL] [Abstract][Full Text] [Related]
12. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
Kim YK; Kim CS; Han YM; Lee YH
Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
[TBL] [Abstract][Full Text] [Related]
13. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
14. Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging.
Lee MH; Kim SH; Kim H; Lee MW; Lee WJ
Korean J Radiol; 2011; 12(4):439-49. PubMed ID: 21852904
[TBL] [Abstract][Full Text] [Related]
15. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
Gu KW; Kim YK; Min JH; Ha SY; Jeong WK
Abdom Radiol (NY); 2017 May; 42(5):1424-1433. PubMed ID: 28078380
[TBL] [Abstract][Full Text] [Related]
16. Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance.
Min JH; Kim YK; Sinn DH; Choi SY; Jeong WK; Lee WJ; Ha SY; Ahn S; Kim MJ
Abdom Radiol (NY); 2018 Sep; 43(9):2309-2320. PubMed ID: 29470629
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
[TBL] [Abstract][Full Text] [Related]
18. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase.
Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G
Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
